Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Arnold G Zermansky a Division of
Academic Pharmacy Practice, School of Healthcare Studies, University of
Leeds, Leeds LS2 9UT, b Department of Primary Care and General
Practice, University of Birmingham, Birmingham B15 2TT, c Biostatistics Group, University
of Manchester, Hope Hospital, Salford, Manchester M6 8HD
Correspondence to: A G
Zermansky arnoldz{at}easynet.co.uk
Objective:
To determine whether a pharmacist can
effectively review repeat prescriptions through consultations with
elderly patients in general practice.
What is already known on this topic
What this study adds
Design:
Randomised controlled trial of clinical
medication review by a pharmacist against normal general practice review.
Setting:
Four general practices.
Participants:
1188 patients aged 65 or over who were
receiving at least one repeat prescription and living in the community.
Intervention:
Patients were invited to a consultation
at which the pharmacist reviewed their medical conditions and current treatment.
Main outcome measures:
Number of changes to repeat
prescriptions over one year, drug costs, and use of healthcare services.
Results:
590 (97%) patients in the intervention group were reviewed compared with 233 (44%) in the control group. Patients seen by the pharmacist were more likely to have changes made to their
repeat prescriptions (mean number of changes per patient 2.2 v
1.9; difference=0.31, 95% confidence interval 0.06 to 0.57; P=0.02). Monthly drug costs rose in both groups over the year, but the
rise was less in the intervention group (mean difference £4.72 per 28 days,
£7.04 to
£2.41); equivalent to £61 per patient a year.
Intervention patients had a smaller rise in the number of drugs
prescribed (0.2 v 0.4; mean difference
0.2,
0.4 to
0.1). There was no evidence that review of treatment by the
pharmacist affected practice consultation rates, outpatient
consultations, hospital admissions, or death rate.
Conclusions:
A clinical pharmacist can conduct
effective consultations with elderly patients in general practice to
review their drugs. Such review results in significant changes in
patients' drugs and saves more than the cost of the intervention
without affecting the workload of general practitioners.
Review of patients on long term drug treatment is important but is done
inadequately
Consultations with a clinical pharmacist are an effective method of
reviewing the drug treatment of older patients
Read all Rapid Responses